Ted Satterthwaite

McLure Associate Professor in Psychiatry and Behavioral Research
University of Pennsylvania

Ted Satterthwaite is McLure Associate Professor in Psychiatry and Behavioral Research at the University of Pennsylvania’s Perelman School of Medicine. He completed medical and graduate training at Washington University in St. Louis, where he was a student of Randy L. Buckner. Subsequently, he was a psychiatry resident and a neuropsychiatry fellow at Penn, under the mentorship of Raquel E. Gur. He joined the faculty of the psychiatry department in 2014 and served as director of imaging analytics at the Brain Behavior Laboratory from 2015 to 2019. Since 2020, he has directed the Penn Lifespan Informatics and Neuroimaging Center. His research uses multi-modal neuroimaging to describe both normal and abnormal patterns of brain development, in order to better understand the origins of neuropsychiatric illness. He has been the principal investigator on nine R01 grants from the National Institutes of Health. His work has been recognized with the Brain and Behavior Research Foundation’s Klerman Prize for Clinical Research, the NIMH Biobehavioral Research Award for Innovative New Scientists (BRAINS) award, the NIH Merit Award, as well as several teaching awards.

From this contributor

Explore more from The Transmitter

Exclusive: Brain and spinal cord institute halts research, citing funding problems

The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.

By Lauren Schenkman
4 June 2026 | 5 min read
Photo collage of Tempest McDonald.

When autistic kids grow up, Chapter 1: Those people

What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?

By Brady Huggett
4 June 2026 | 24 min listen
Headshots of Yale researchers Yong-Hui Jiang and Jiangbing Zhou.

Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions

Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.

By Natalia Mesa
3 June 2026 | 11 min read